Work

Alvocidib Enhances Venetoclax Sensitivity in Unfavorable-Risk Multiple Myeloma Cells In Vitro and In Vivo

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.2540.2540

Authors: Liang Zhou, Yu Zhang, Deepak Sampath, Joel D. Leverson, Yun Dai, Maciej Kmieciak, Matthew Nguyen, Robert Z. Orlowski, Steven Grant

Institutions: Virginia Commonwealth University, Genentech, AbbVie (United States), VCU Massey Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3168087597

FWCI:

Cites:

Cited by:

Related to: 20